Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure

Gut

Volumn 46, Issue 4, 2000, Pages 527-533

  Jalan, R ^a   Hayes, P C ^a  

^a Department of Medicine   (United Kingdom)

Author keywords

Angiotensin; Cirrhosis; Peripheral vasodilatation; Sodium handling; TIPSS; Transjugular intrahepatic portosystemic stent shunt

Indexed keywords

ANGIOTENSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PLASMA RENIN ACTIVITY; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; SODIUM RETENTION; VASODILATATION;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL PRESSURE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RENAL PLASMA FLOW; SODIUM;

EID: 0034121345     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.4.527     Document Type: Article

References (43)

1. 1 Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958;32:358-67.
2. 2 Kontos HA, Shapiro W, Mauck HP, et al. General and regional circulatory alterations in cirrhosis of the liver. Am J Med 1964;37:526-35.
3. 3 Kowalski HJ, Ahelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953;32:1025-33.
4. 4 Bendtsen F, Henriksen JH, Sorensen TIA, et al. Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic haemodynamics. J Hepatol 1900;10:198-204.
5. 5 Bernardi M, Trevisani F, Santini C, et al. Impairment of blood pressure control in patients with liver cirrhosis during tilting: study on adrenergic and renin-angiotensin systems. Digestion 1982;25:124-30.
6. 6 Arroyo V, Bosch J, Mauri M, et al. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 1981;11:221-9.
7. 7 Pariente EA, Bataille C, Bercoff E, et al. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. Gastroenterology 1985;88:1255-9.
8. 8 Ryan J, Sudhir K, Jennings G, et al. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 1993,105:1167-72.
9. 9 Martinet JP, Legault L, Cernacek P, et al. Changes in plasma endothelin-1 and big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 1996;25:700-6.
10. 10 Schroeder ET, Anderson GH, Goldman SH, et al. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis. Kid Intern 1976;9:511 19.
11. 11 Floras JS, Legault L, Morali GA, et al. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med 1991;114:373-80.
12. 12 Henriksen JH, Christensen NJ, Ring-Larsen H. Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis. Relation to haemodynamics. Clin Physiol 1981;1:293-304.
13. 13 Bichet DG, Van Putten VJ, Schrier RW. Potential role of incresed sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982,307:1552-7.
14. 14 Bichet DG, Szatalowicz V, Chaimovitz C, et al. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Int Med 1982;96:413-17.
15. 15 Reznick RK, Langer B, Taylor BR, et al. Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting. Gastroenterology 1983;84:71 3-18.
16. 16 Bichet DG, Groves BM, Schrier RW. Mechanisms of improvement of water and sodium excretion by immersion in decompensated cirrhotic patients. Kid Intern 1983;24: 788-94.
17. 17 Epstein M, Weitzman RE, Preston S, et al. Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis. Miner Electrolyte Metab 1984;10:155 65.
18. 18 Sherlock S, Shaldon S. The aetiology and management of ascites in patients with cirrhosis. A review. Gut 1963;4:95 105.
19. 19 Leiberman FL, Ito S, Reynolds TB. Effective plasma volume in cirrhosis with ascites: evidence that a decreased value does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug induced diuresis. J Clin Invest 1969;48:975.
20. 20 Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
21. 21 Wong F, Sniderman K, Liu P, et al. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997;112:899-907.
22. 22 Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:986-94.
23. 23 Jalan R, Redhead DN, Thomas HW, et al. Mechanisms of changes in renal handling of sodium following transjugular intrahepatic portal systemic stent-shunt (TIPSS). Eur J Gastroenterol Hepatol 1996;8:1111-16.
24. 24 Gerbes AL, Gulberg V, Waggershauser T, et al. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 1998;28: 683-8.
25. 25 Wong F, Massie D, Hsu P, et al. Renal response to a saline load in well-compensated alcoholic cirrhosis. Hepatotogy 1994;20:873-81.
26. 26 Stanley AJ, Forrest EH, Dabos K, et al. Natriuretic effect of an adenosine-1 receptor antagonist in cirrhotic patients with ascites. Gastroenterology 1998;115:406 11
27. 27 Cody RJ, Haas GJ, Binkley PF, et al. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504 9.
28. 28 Wong F, Massie D, Colman J, et al. Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis. Gastroenterotogy 1993;104:884-9.
29. 29 Lang F, Tschernko E, Schulze E, et al. Hepatorenal reflex regulating kidney function. Hepatology 1991;14:590-4.
30. 30 DiBona GF, Sawin LL. Hepatorenal baroreflex in cirrhotic rats. Am J Physiol 1995;269:G29-33.
31. 31 Jalan R, Forrest EH, Redhead DN, et al. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut 1997;40:664-70.
32. 32 Sellars L, Shore AC, Wilkinson R, et al. Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease. Eur J Clin Invest 1981;11:299 304.
33. 33 Wong F, Sniderman K, Blendis L. The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis, Gastroenterology 1998;115:397-405.
34. 34 Helmy A, Jalan R, Newby DE, et al. Role of renin angiotensin and sympathetic nervous systems in regulation of peripheral vascular tone in patients with refractory ascites [abstract]. Hepatology 1998:28:449A.
35. 35 Girgrah N, Liu P, Blendis L, Wong F. The effect of losartan, an angiotensin II receptor antagonist, on systemic and renal hemodynamics and sodium homeostasis in cirrhosis [abstract], Hepatology 1997;41:A233.
36. 36 Gerbes AL, Moller S, Gulberg V, et al. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 1995;21:735-9.
37. 37 Newby DE, Jalan R, Masumori S, et al. Impaired central but stimulated humoral regulation of vascular tone in patients with cirrhosis and ascites. Cardiovasc Res 1998;38:221-8.
38. 38 Asbert M, Gines A, Gines P, et al. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993;104:1485-91.
39. 39 Salo J, Francitorra A, Follo A, et al. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. J Hepatol 1995;22:389-98.
40. 40 Wong F, Logan A, Blendis L. The effect of varying sodium intake on blood volume, forearm blood flow and vascular responsiveness to sympathetic stimulation in pre-ascitic cirrhosis. Clin Invest Med 1996;19:184-94.
41. 41 Woitas RP, Heller J, Stoffel-Wagner B, et al Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis. Hepatology 1997;26:858-64.
42. 42 Tajiri K, Miyakawa H, Izumi N, et al. Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide. Hepatology 1995;22:1430-5.
43. 43 Niederberger M, Gines P, Tsai P, et al. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilatation in cirrhosis. Hepatology 1995;21:1625-31.